|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 320.20 SEK | +6.88% |
|
+10.55% | +3.15% |
| 02-20 | Nordea Raises Price Target for Bioarctic to 240 Kronor (236), Reiterates Sell | FW |
| 02-19 | Lannebo Health and New Technology Down 5.1 Percent in January — Bico and Raysearch Weigh on Performance | FW |
| Capitalization | 26.58B 2.89B 2.49B 2.25B 2.16B 3.92B 266B 4.1B 10.66B 127B 10.85B 10.62B 457B | P/E ratio 2025 |
27x | P/E ratio 2026 * | 454x |
|---|---|---|---|---|---|
| Enterprise value | 24.59B 2.67B 2.31B 2.08B 2B 3.63B 246B 3.79B 9.86B 118B 10.04B 9.82B 423B | EV / Sales 2025 |
13.8x | EV / Sales 2026 * | 21.1x |
| Free-Float |
44.08% | Yield 2025 * |
-
| Yield 2026 * | 0.67% |
Last Transcript: BioArctic AB
| 1 day | +6.88% | ||
| 1 week | +10.55% | ||
| Current month | +3.82% | ||
| 1 month | -1.66% | ||
| 3 months | +1.52% | ||
| 6 months | +17.69% | ||
| Current year | +3.15% |
| 1 week | 286.6 |  | 323.8 |
| 1 month | 286.6 | | 364.4 |
| Current year | 284 | | 364.4 |
| 1 year | 154.4 | | 364.4 |
| 3 years | 137.7 | | 392 |
| 5 years | 66.7 | | 392 |
| 10 years | 20.4 | | 392 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/01/2013 | |
| Director of Finance/CFO | 55 | 01/06/2023 | |
Johanna Fälting
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/01/2012 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 79 | 24/01/2003 | |
| Chairman | 77 | 28/01/2003 | |
Eugen Steiner
CHM | Chairman | 72 | 01/06/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.42% | 1.25% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.88% | +10.55% | +46.39% | +22.84% | 2.89B | |
| -0.31% | -4.13% | -8.71% | -6.97% | 44.96B | |
| +1.50% | +3.29% | +26.44% | +41.89% | 33.54B | |
| +0.98% | -13.63% | +16.43% | +43.10% | 30.24B | |
| -2.88% | -0.49% | -8.30% | -12.24% | 29.97B | |
| +0.68% | -0.16% | +172.49% | +383.29% | 19.78B | |
| +0.63% | +0.74% | +74.40% | +126.89% | 14.73B | |
| -1.39% | +1.10% | +39.45% | +168.20% | 13.58B | |
| +0.41% | -3.57% | +22.05% | +0.54% | 12.97B | |
| +1.39% | -2.80% | +137.31% | +125.15% | 12.45B | |
| Average | +0.78% | -1.65% | +51.80% | +89.27% | 21.51B | |
| Weighted average by Cap. | +0.11% | -1.69% | +36.80% | +71.56% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 1.99B 217M 187M 169M 162M 294M 19.97B 308M 800M 9.55B 814M 796M 34.29B | 1.23B 134M 115M 104M 99.88M 182M 12.33B 190M 493M 5.9B 502M 491M 21.16B |
| Net income | 1B 109M 93.95M 84.84M 81.3M 148M 10.03B 154M 402M 4.8B 409M 400M 17.22B | 286M 31.12M 26.85M 24.24M 23.23M 42.23M 2.87B 44.15M 115M 1.37B 117M 114M 4.92B |
| Net Debt | -1.99B -217M -187M -169M -162M -294M -19.95B -307M -799M -9.54B -813M -796M -34.25B | -568M -61.75M -53.27M -48.1M -46.1M -83.78M -5.69B -87.6M -228M -2.72B -232M -227M -9.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/03/26 | 321.20 kr | +7.21% | 200,310 |
| 09/03/26 | 299.60 kr | +0.27% | 162,475 |
| 06/03/26 | 298.80 kr | -0.40% | 154,136 |
| 05/03/26 | 300.00 kr | +0.20% | 125,207 |
| 04/03/26 | 299.40 kr | +3.24% | 145,477 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIOA B Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition